Bio

Alisha Alaimo is a dynamic global executive with an extensive track-record of driving double-digit growth in biotech and pharma organizations during key inflection points. During her 25 year career, she has led more than 15 product launches in the US and Europe in organizations with up to $7B in annual revenue. Alaimo brings an in-depth understanding of the market dynamics in a breadth of therapeutic areas including cardiovascular, metabolic, anti-infectives, respiratory, pain, immunology, rare disease, transplant and neuroscience. She is skilled at building market confidence and engaging with investors in high-profile situations. Alaimo embeds digital transformation into her team’s purpose and accelerates innovations by creating a culture where any team member can improve outcomes through the power of iterative progress. Alaimo believes that solving today’s complex healthcare problems requires strategic collaboration, which has driven her to create partnerships with the world’s leading technology and healthcare organizations including Amazon, CVS Health, Twill, GoodRx, Lab Corp and Mayo Clinic. Alaimo is experienced in strengthening governance, driving organizational redesigns, and developing leadership and talent for organizations of 2,000+. She creates a culture that values diverse perspectives and embraces productive conflict to identify the best ideas. Most significantly, her leadership teams are grounded and guided by the significance of the organization’s work—to help patients, families, healthcare providers and partners.